Medicus Pharma Ltd.

Healthcare · Drug Manufacturers - General · United States

Last price 2.15 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.72M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was inco...